Spots Global Cancer Trial Database for plb1001
Every month we try and update this database with for plb1001 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas | NCT02978261 | Glioma | PLB1001 | 18 Years - | Beijing Pearl Biotechnology Limited Liability Company | |
A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2) | NCT05989542 | Non-small Cell ... | PLB1001 | 18 Years - | Beijing Pearl Biotechnology Limited Liability Company | |
First-in-human Phase I Study of a Selective c-Met Inhibitor PLB1001 | NCT02896231 | Non-Small Cell ... | PLB1001 | 18 Years - | Beijing Pearl Biotechnology Limited Liability Company | |
A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG) | NCT04258033 | Non-small Cell ... | PLB1001 | 18 Years - | Beijing Pearl Biotechnology Limited Liability Company |